Wilkins Miller Wealth Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
62,568
-4,496
-7% -$113K 0.87% 33
2026
Q1
$1.69M Buy
67,064
+2,887
+4% +$73.7K 1.03% 30
2025
Q4
$1.64M Buy
64,177
+989
+2% +$25.3K 0.98% 30
2025
Q3
$1.62M Buy
63,188
+7,843
+14% +$199K 1% 28
2025
Q2
$1.4M Sell
55,345
-6,478
-10% -$161K 0.95% 27
2025
Q1
$1.54M Buy
61,823
+136
+0.2% +$3.36K 1.16% 25
2024
Q4
$1.52M Buy
+61,687
New +$1.54M 1.59% 17

Other funds holding IBDX

Wilkins Miller Wealth Management's IBDX Position: Q2 2026 in Review

Wilkins Miller Wealth Management reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 6.7% in Q2 2026, selling an estimated $113K and leaving 62,568 shares worth $1.58M. The position accounts for 0.87% of the portfolio, ranked #33.

Wilkins Miller Wealth Management first reported a position in IBDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.69M in Q1 2026. 52 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Wilkins Miller Wealth Management held 62,568 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.58M as of Q2 2026.
  • Wilkins Miller Wealth Management sold 4,496 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $113K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.87% of Wilkins Miller Wealth Management's portfolio in Q2 2026, its #33 holding.
  • Wilkins Miller Wealth Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • Wilkins Miller Wealth Management's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $1.69M in Q1 2026.
  • 52 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Wilkins Miller Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.